Form 4 for ADCT ADC Therapeutics SA
Accepted 2024-05-09 00:00:00 ET · period of report 2024-05-07 · accession 0001628280-24-022207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-09 | 2024-05-07 | ADCT | MALLIK AMEET | CEO, Dir | S - Sale | $4.48 | -29.7K | 1.17M | -2% | -$133.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-05-07 | S | D | 29,731 | $4.48 | 1,167,348 | D | — | — |